Auto-injectors Market size was over USD 9.27 billion in 2024 and is poised to cross USD 41.88 billion by the end of 2037, witnessing more than 12.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of auto-injectors is estimated at USD 10.18 billion. The reason behind the growth is impelled by the rising cases of rheumatoid arthritis. Hand disabilities can make it more difficult for individuals with rheumatoid arthritis (RA) to use syringes to give medication as part of their therapy therefore, auto-injectors could potentially mitigate this problem as by using them patients can administer etanercept a medicine used to treat rheumatoid arthritis on their own, in the comfort of their own homes, using an auto-injection pen-like device. Globally, more than 17 million cases of rheumatoid arthritis were reported in 2020.
The growing government initiatives to increase awareness are believed to fuel the market growth. For instance, on June 2023 the Medicines and Healthcare Products Regulatory Agency (MHRA), in collaboration with allergy awareness advocates, released new guidelines outlining the most recent safety recommendations for what to do in the event of anaphylaxis and offered guidance on how to use adrenaline auto-injectors.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?